Dermatology Unit, Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland.
Vet Dermatol. 2021 Jun;32(3):247-e65. doi: 10.1111/vde.12940. Epub 2021 Feb 10.
The gold standard to diagnose food allergy in dogs is an eight week elimination diet trial (EDT) followed by a re-challenge. A recent study demonstrated that a shorter EDT is possible if prednisolone is administered initially.
HYPOTHESIS/OBJECTIVES: The goal was to evaluate the sensitivity and specificity of the EDT based on the number of relapses after prednisolone discontinuation. In addition, the aim was to determine whether the initial treatment length or the replacement of prednisolone with oclacitinib would influence the outcome.
Eighty-seven dogs with atopic dermatitis.
Dogs were fed an elimination diet and treated with either prednisolone or oclacitinib for two to three weeks. Relapsing dogs were treated a second time. In the absence of a relapse after two weeks off medication, dogs then were challenged. Dogs never achieving two weeks off treatment without relapse received the regular EDT.
Fifty-eight of 87 dogs completed the study. Thirty-nine of 58 dogs received prednisolone; 21 of these were diagnosed with FIAD and had no relapse (n = 14), one relapse (n = 6) or two relapses (n = 1). Nineteen of 58 dogs received oclacitinib; 11 of these were deemed food-allergic and had no relapse (n = 7) or two relapses (n = 4). The initial treatment duration did not influence the outcome. The threshold of one relapse or less for the diagnosis of FIAD was associated with a sensitivity of 95% for prednisolone and 63% for oclacitinib. The specificity was 100% for both drugs.
Initial prednisolone or oclacitinib use in EDT shortens the time to diagnosis of FIAD.
诊断犬食物过敏的金标准是进行为期八周的饮食排除试验(EDT),然后进行再挑战。最近的一项研究表明,如果最初给予泼尼松龙,则可以进行更短的 EDT。
假设/目的:本研究的目的是评估基于泼尼松龙停药后复发次数的 EDT 的敏感性和特异性。此外,还旨在确定初始治疗时间或用奥克利替尼替代泼尼松龙是否会影响结果。
87 只特应性皮炎犬。
狗食用排除饮食,并接受泼尼松龙或奥克利替尼治疗两到三周。复发的狗接受第二次治疗。如果停药两周后没有复发,则狗接受再挑战。如果停药两周内没有复发,则狗接受常规 EDT。
87 只狗中有 58 只完成了研究。58 只狗中有 39 只接受了泼尼松龙治疗;其中 21 只被诊断为 FIAD,无复发(n=14)、一次复发(n=6)或两次复发(n=1)。58 只狗中有 19 只接受了奥克利替尼治疗;其中 11 只被认为是食物过敏,无复发(n=7)或两次复发(n=4)。初始治疗时间并未影响结果。FIAD 诊断的复发次数少于或等于 1 的阈值与泼尼松龙的敏感性为 95%和奥克利替尼的敏感性为 63%相关。两种药物的特异性均为 100%。
EDT 中初始使用泼尼松龙或奥克利替尼可缩短 FIAD 的诊断时间。